Effects of Su Jok Seed Therapy Application on Pain, Anxiety and Psychological Resilience in Patients Hospitalized in the Oncology Ward

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMuş Alparslan University

About this trial

The aim of this clinical trial is to determine the effects of su jok seed therapy on pain, anxiety and psychological resilience in patients hospitalized in the oncology ward. This study seeks answers to the following questions; Does su jok seed therapy affect the pain levels of cancer patients? Does su jok seed therapy affect the anxiety levels of cancer patients? Does su jok seed therapy affect the Psychological resilience levels of cancer patients? There will be an experimental and control group in the study and the effectiveness of sujok application will be examined.

A total of 8 sessions of su jok seed therapy will be applied to the experimental group, twice a week for a month. No intervention will be made to the control group.

Individuals over 18 years old, without communication problems and diagnosed with cancer will be included in the sample.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being over 18 years old,

No communication problems,

Individuals diagnosed with cancer

Disqualifiers

Getting worse or dying during the research process

Trial design

Design model

Crossover

Treatments tested in this trial

  • Su-Jok

    Device

    Su-jok seed therapy

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Su-jok Therapy Group /EXPERIMENTAL GROUPExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Pain levels of cancer patients will be evaluated using VAS.

Pain levels of cancer patients

Time frame
2 months
2

Anxiety levels of cancer patients will be evaluated using the "State Anxiety Scale".

Anxiety levels of cancer patients

Time frame
2 months
3

Psychological resilience levels of cancer patients will be evaluated using the "Brief Psychological Resilience Scale".

Psychological resilience levels of cancer patients

Time frame
2 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: